Key statistics
As of last trade, CareDx Inc (1K9:FRA) traded at 16.42, 67.02% above the 52 week low of 9.83 set on Aug 20, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 16.42 |
|---|---|
| High | 16.42 |
| Low | 16.42 |
| Bid | 16.41 |
| Offer | 16.75 |
| Previous close | 15.91 |
| Average volume | 174.86 |
|---|---|
| Shares outstanding | 51.43m |
| Free float | 49.15m |
| P/E (TTM) | 24.37 |
| Market cap | 1.01bn USD |
| EPS (TTM) | 0.8055 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:06 GMT.
More ▼
Press releases
- CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
- CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
- CareDx to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- CareDx Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
- CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
- CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
More ▼
